Investing.com -- Wells Fargo has initiated coverage of Zealand Pharma (NASDAQ: ZEAL) with an Overweight rating and a DKK 650 ...

Roche Holding AG's H2 2025 earnings show solid growth in pharma revenues but highlight pipeline struggles and U.S. pricing pressures. Click for my RHHBY update.

Roche’s move came against a backdrop of wider industry retreat from gene therapy, with Pfizer pulling its FDA-approved ...

The latest round of terminations, which will take effect Sept. 15, comes after Genentech fired more than 500 employees in the ...

In 2022, over 1 billion people were affected by obesity, driving innovation in therapeutic advancements. Emerging treatments focus on appetite contro ...

Dealmaking in Europe’s life sciences sector has been relatively muted in recent years, but the first half of 2025 has shown signs of strength ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.

The victims — Easton Janet Taylor from the U.K. and Alison Jean Taylor from New Zealand — were attacked by a female elephant that was with a calf, police said.

Government disburses ₹10,114 crore in PLI schemes, boosting electronics and pharmaceutical manufacturing, driving export growth.

Morgan Stanley sees earnings growth in the pharma sector moderating in FY25–27, though robust balance sheets could support investments in high-growth areas.